Aripiprazole Tablet
Product Images NDC 50268-088

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 50268-088). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-6 (Figure 6)

A line graph comparing the proportion of subjects with relapse over 182 days from randomization between Aripiprazole and placebo groups. The x-axis shows days from randomization, and the y-axis shows the proportion with relapse. The graph includes a table below indicating the number of subjects at risk at various time points for both groups.*

FDA Label Image

Figure1 (Figure1)

A graph titled 'Effect of Other Drugs on Aripiprazole' showing fold change and 90% confidence intervals for pharmacokinetic parameters AUC and Cmax. It compares changes relative to a reference without interacting drugs for various inhibitors, inducers, gastric acid blockers, and other drugs such as ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam.*

FDA Label Image

Figure2 (Figure2)

A chart titled 'Effect of Other Drugs on Aripiprazole' showing the fold change and 90% confidence intervals of dehydro-aripiprazole pharmacokinetics parameters (AUC and Cmax) relative to a reference without interacting drugs. The graph compares the effects of CYP3A4 inhibitors (ketoconazole), CYP2D6 inhibitors (quinidine), CYP3A4 inducers (carbamazepine), gastric acid blockers (famotidine), and other drugs including valproate, lithium, and lorazepam on Aripiprazole exposure.*

FDA Label Image

Figure3 (Figure3)

A forest plot chart showing the effect of Aripiprazole on pharmacokinetic parameters of various drugs. The chart plots fold change and 90% confidence intervals for metrics such as AUC, Cmax, DMDRP, and INR relative to a reference without interacting drug, for drugs including dextromethorphan, S-warfarin, R-warfarin, omeprazole, lamotrigine, valproate, lithium, lorazepam, venlafaxine, and O-desmethylvenlafaxine.*

FDA Label Image

Figure4 (Figure4)

A forest plot chart titled 'Aripiprazole Fold Change and 90% CI' showing pharmacokinetic comparisons of Aripiprazole in special populations. Variables include CYP2D6 poor vs. extensive metabolizers, gender, age groups, hepatic impairment (mild, moderate, severe), and severe renal impairment. The chart plots fold changes in AUC and Cmax with 90% confidence intervals relative to reference populations.*

FDA Label Image

Figure5 (Figure5)

A chart illustrating the fold change and 90% confidence interval for dehydro-aripiprazole pharmacokinetics (AUC and Cmax) across various factors: CYP2D6 metabolizer status, gender, age groups, hepatic impairment severities, and severe renal impairment. The x-axis represents change relative to reference from 0.5 to 3.0.*

FDA Label Image

Formula (Screen Shot 2016 04 28 At 11.33.28 Am)

Chemical structure of Aripiprazole showing its molecular configuration, including chlorinated aromatic rings and nitrogen-containing heterocycles.*

FDA Label Image

2mg Label (Screen Shot 2016 04 29 At 12.00.43 Pm)

Aripiprazole Tablets 2 mg oral tablets label by AvPAK. Packaging holds 20 tablets (2 x 10 unit dose). Label includes NDC 50268-087-12, barcode, directions for pharmacist to dispense Medication Guide, dosing information stating 2 mg per tablet, storage instructions, contact information, and manufacturer details from AvKARE, Inc., Pulaski, TN.*

FDA Label Image

5mg Label (Screen Shot 2016 04 29 At 12.01.00 Pm)

Aripiprazole Tablets 5 mg oral tablets label from AvPAK. The label states quantity as 50 tablets (5 x 10) unit dose and includes instructions for pharmacist to dispense the medication guide separately. Manufacturer contact information and handling instructions are also visible along with the AvPAK logo at the bottom.*

FDA Label Image

10mg Label (Screen Shot 2016 04 29 At 12.01.16 Pm)

Aripiprazole Tablets 10 mg oral tablets label by AvPAK. The label indicates the product contains 50 tablets (5 x 10 unit dose). It includes Rx only status, NDC 50268-089-15, a barcode, pharmacist dispensing instructions, dosage and storage information, contact number, and manufacturer details in Pulaski, TN.*

FDA Label Image

15mg Label (Screen Shot 2016 04 29 At 12.01.32 Pm)

Aripiprazole 15 mg tablets label from AvPAK, showing each tablet contains 15 mg of aripiprazole. The unit dose package contains 20 tablets (2 x 10). Label includes prescription-only (Rx Only) status, storage instructions, and a warning box stating medication guide is provided separately to each patient. Manufacturer contact and location in Pulaski, TN are visible.*

FDA Label Image

20mg Label (Screen Shot 2016 04 29 At 12.01.50 Pm)

Aripiprazole Tablets 20 mg oral tablets labeled for prescription use only, packaged as 20 tablets (2 x 10) unit dose. The label includes the NDC 50268-091-12, barcode, storage instructions, contact information, and manufacturing details by AvPAK, Inc. Warning notes and pharmacist instructions are also visible.*

FDA Label Image

30mg Label (Screen Shot 2016 04 29 At 12.02.03 Pm)

Aripiprazole Tablets 30 mg oral tablets packaging label from AvPAK. The label shows a quantity of 20 tablets (2 x 10 unit dose) with NDC 50268-092-12. It includes a pharmacist instruction to dispense medication guide separately and contains storage and contact information along with the manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.